Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6631
Reference
MSAN(2019)08
Name
Medicine Supply Alert Notice: medicine in short supply: Ongentys® (opicapone) 50mg capsules
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
This Medicine Supply Alert Notice provides information regarding the current supply issues for Ongentys® (opicapone) 50mg capsules. Bial Pharma are the sole suppliers of Ongentys®. Production of Ongentys® has been affected by a production incident at the Active Pharmaceutical Ingredient (API) manufacturer site. The supply issue affects the global supply of opicapone.
Contact Name
Contact Email
Contact Address
Contact Phone
Created
2019-10-28 00:00:00
Click to go back to homepage